http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2022505053-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2020-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2022505053-A |
| titleOfInvention | BTK inhibitors, their pharmaceutically acceptable salts and crystalline polymorphs, and their applications |
| abstract | The present invention provides BTK inhibitors and pharmaceutically acceptable salts thereof, polymorphs thereof and applications thereof. Specifically, the present invention relates to (R) -6-((1-acryloylpiperidin-3-yl) amino) -7-fluoro-4-((2-fluoro-4-morpholinophenyl) amino) -1. , 2-Dihydro-3H-pyrrolo [3,4-c] Pyridine-3-one or a pharmaceutically acceptable salt thereof, a polymorph of crystals and applications thereof. Furthermore, the present invention discloses a pharmaceutical composition containing the inhibitor and its application. [Selection diagram] None |
| priorityDate | 2019-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 36.